QMS Medical Allied Services’ Rs 12.5 Crore Rights Issue opens

IMT News Desk
IMT News Desk
· 2 min read

Strengthens healthcare expansion strategy

QMS Medical Allied Services opened its Rights Issue to raise Rs 12.5 crore. The Issue comprises 14,87,500 equity shares of face value Rs 10 each, offered at an Issue Price of Rs 81 per share (including a premium of Rs 71 per share).

The proceeds from the Rights Issue will be strategically utilised to strengthen QMS Medical Allied Services’ growth trajectory. A significant portion, amounting to Rs 10 crore, will be invested towards acquiring an additional 25 per cent stake in its subsidiary, Saarathi Healthcare, thereby increasing QMS Medical Allied Services’ holding to 76 per cent. The balance funds will be deployed to meet working capital requirements and for general corporate purposes, ensuring enhanced operational flexibility and sustained business expansion.

Mahesh Makhija, Founder, Chairman and Managing Director, QMS Medical Allied Services said, “The Rights Issue will support our planned acquisition of an additional 25 per cent stake in Saarathi Healthcare Private Limited, further consolidating our position in the value-added segment of the healthcare industry. This strategic investment reinforces our commitment to expanding QMS Medical Allied Services’ footprint in high-growth verticals, enhancing operational synergies, and unlocking long-term value for all stakeholders. “India’s healthcare sector continues to experience unprecedented growth, driven by rising demand for advanced medical solutions. At QMS Medical Allied Services, we remain steadfast in our mission to deliver accessible, high-quality, and dependable healthcare products and services across the country. This Rights Issue is not just a step towards accelerating our strategic initiatives, but also a valuable opportunity for our shareholders to strengthen their association with QMS Medical Allied Services and participate in our journey of sustained growth and innovation,” Makhija added.

Read Next

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk
National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare
News
May 18, 2026

National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare

The National AI Doctors Mission (NAIDM) has been formally launched in New Delhi, marking a major step toward integrating artificial intelligence into everyday clinical practice across India’s public and private healthcare system. The initiative, led by Medical Dialogues in collaboration with the National Medical Forum, aims to make AI “useful and usable” for frontline doctors rather than […]
Article by: IMT News Desk
Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore
News
May 18, 2026

Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore

Gland Pharma shares extended gains in the capital markets after the company posted a standout Q4 performance, with consolidated net profit jumping 97% year‑on‑year to ₹367 crore, riding on a sharp improvement in operating leverage and a strong base‑business showing in the US. Revenue for the quarter rose 22% YoY to ₹1,743 crore, while EBITDA surged 48% YoY […]
Article by: IMT News Desk